S&P 500
(-0.10%) 5 463.61 points
Dow Jones
(0.07%) 39 139 points
Nasdaq
(0.08%) 17 732 points
Oil
(-0.04%) $80.80
Gas
(-5.04%) $2.62
Gold
(-0.87%) $2 310.60
Silver
(-0.30%) $28.78
Platinum
(3.19%) $1 017.90
USD/EUR
(0.35%) $0.936
USD/NOK
(0.75%) $10.68
USD/GBP
(0.54%) $0.793
USD/RUB
(-0.27%) $87.26

Sanntidsoppdatering for Pluristem Therapeutics [PSTI]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert26 jul 2022 @ 06:00

-2.91% $ 1.000

Live Chart Being Loaded With Signals

Commentary (26 jul 2022 @ 06:00):

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders...

Stats
Dagens volum 170 627
Gjennomsnittsvolum 0
Markedsverdi 40.85M
EPS $-0.310 ( Q3 | 2022-05-09 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.684
(Sector) 42.63
(Industry) 24.32
ATR14 $0.104 (10.40%)
AADI -8.24%
ABCL 0.55%
ABCM 0.04%
ABEO -3.32%
ABIO -1.68%
ABOS 3.73%
ABSI 3.74%
ABUS -0.82%
ABVX -3.00%
ACAD -0.45%
ACER -17.95%
ACET -8.89%
ACGN 1.29%
ACHL -2.48%
ACHV 3.56%
ACIU -1.50%
ACLX -0.30%
ACRV -5.28%
ACST -1.68%
ACXP 3.92%
ADAG 6.07%
ADAP -3.42%
ADGI 0.87%
ADIL -1.75%
ADMA -1.95%
ADPT 1.03%
ADTX -2.78%
ADVM 1.01%
ADXN -1.60%
AEON -2.80%
AEZS -2.49%
AFMD -2.62%
AGEN -3.56%
AGIO -2.09%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 4.26%
AKRO -2.68%
AKTX 0.35%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC -0.11%
ALGS -1.52%
ALKS 1.70%
ALLK -11.02%
ALLO -4.17%
ALLR -0.10%
ALNA 3.16%
ALNY 2.03%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -14.24%
ALVR -0.74%
ALXN 0.00%
ALXO -14.16%
ALZN 4.02%
AMRN -1.26%
AMTI -3.13%
ANAB 1.00%
ANEB 6.06%
ANGN 0.00%
ANIX -3.04%
ANL -0.14%
ANNX 1.97%
ANPC -3.15%
APGE 0.52%
APGN 8.48%
APGNW 30.65%
APLM -5.90%
APLS 0.65%
APLT -1.13%
APM 1.26%
APOP 0.38%
APRE 0.84%
APTO 0.62%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -6.49%
ARDS -12.13%
ARDX 0.42%
ARGX -0.59%
ARNA 0.00%
ARPO -0.90%
ARQT -3.28%
ARTL -2.50%
ARTLW 0.00%
ARVN 7.92%
ARWR -1.79%
ASLN -3.44%
ASMB -4.22%
ASND -2.14%
ATAI -4.81%
ATHA 6.89%
ATHE 0.56%
ATHX -33.50%
ATNF 0.99%
ATOS 5.34%
ATRA -3.60%
ATXI -2.77%
ATXS -0.78%
AUPH -1.17%
AURA 4.26%
AUTL -3.60%
AVBP -6.52%
AVEO 0.00%
AVIR -2.19%
AVRO -1.41%
AVTE -1.03%
AVTX -3.74%
AVXL -5.43%
AXLA 0.00%
AXSM -1.47%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.71%
BCAB -5.56%
BCDA -3.75%
BCDAW -41.77%
BCEL 0.00%
BCLI 3.86%
BCRX 1.73%
BCTX 10.31%
BCTXW 13.02%
BCYC 1.00%
BDRX -4.06%
BDTX -0.32%
BEAM 2.25%
BFRA -2.91%
BGNE -2.25%
BIOR -4.69%
BIVI 2.79%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -3.18%
BLTE -1.13%
BLU 0.03%
BLUE -2.28%
BMEA -14.20%
BMRN 0.49%
BNOX 6.15%
BNTC -3.06%
BNTX -1.80%
BOLD -9.03%
BOLT -0.05%
BPMC -1.56%
BPTH -1.43%
BPTS -13.47%
BRNS -0.37%
BRTX -5.19%
BTAI 12.29%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.36%
CABA 1.52%
CADL 0.71%
CALA 0.00%
CALC -9.65%
CALT -1.59%
CAPR -0.43%
CARA -3.23%
CARM 7.39%
CASI 4.08%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.56%
CCCC -2.55%
CCXI 0.00%
CDAK 0.00%
CDIO -2.99%
CDIOW 24.00%
CDMO -1.41%
CDMOP 0.04%
CDT -1.70%
CDTTW -39.60%
CDTX -6.44%
CDXC 7.58%
CDXS 8.62%
CELC -3.58%
CELU 2.67%
CELUW 11.80%
CERC -1.68%
CERE -1.45%
CERO -6.73%
CEROW -10.18%
CFRX -27.95%
CGEM -0.24%
CGEN -3.31%
CGON -1.45%
CGTX -4.35%
CHMA -6.00%
CHRS 4.11%
CINC 0.00%
CING 2.22%
CINGW 34.95%
CKPT -1.91%
CLBS -16.75%
CLDX -1.19%
CLGN 0.00%
CLLS -3.13%
CLNN -2.72%
CLNNW 0.00%
CLRB 7.01%
CLSD -2.40%
CLSN -0.68%
CLVS 0.00%
CMMB -3.89%
CMND 4.80%
CMPI 0.00%
CMPX 0.00%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.38%
CNCE 0.00%
CNSP -35.22%
CNST 0.00%
CNTA 0.67%
CNTB -0.75%
CNTX -6.16%
COCP -2.00%
COEPW 32.45%
COGT -2.29%
CORT 2.40%
COYA -0.49%
CPRX -1.88%
CRBP -0.74%
CRBU -7.10%
CRDF 0.66%
CRGX -0.74%
CRIS -1.59%
CRNX -6.37%
CRSP -0.05%
CRTX 2.63%
CRVO -3.95%
CRVS 0.56%
CSBR -0.19%
CTCX -1.59%
CTIC 0.06%
CTMX -3.31%
CTNM 1.98%
CTXR -1.19%
CUE -3.11%
CVAC -7.20%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 8.49%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.90%
CYTO 0.00%
DARE 2.92%
DAWN -0.90%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 28.51%
DNLI -2.10%
DNTH -6.27%
DOMH 1.59%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW 0.00%
DRUG 1.43%
DSGN -2.71%
DTIL 0.63%
DYAI 9.68%
EARS -1.77%
EDIT -3.01%
EDSA 4.09%
EFTR 2.51%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 8.40%
ELEV -2.07%
ELOX 10.77%
ELTX -5.15%
ELVN -1.17%
ELYM 5.09%
ENGN 0.86%
ENGNW 0.00%
ENLV 0.00%
ENOB 1.79%
ENSC 6.53%
ENTA -0.73%
ENTO -4.97%
ENTX -1.33%
ENVB 4.72%
EPIX -0.72%
EPRX -1.92%
EPZM 0.00%
EQ -0.90%
EQRX -2.09%
EQRXW 0.00%
ERAS 1.20%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -4.45%
ETON 2.90%
ETTX 0.00%
EVAX -0.71%
EVGN 5.00%
EVLO 0.00%
EWTX -0.86%
EXAI -0.76%
EXEL 0.45%
EYEG -0.69%
EYEN 0.00%
EYPT 0.97%
FATE -12.08%
FBIO 0.59%
FBIOP 0.87%
FBLG -4.80%
FBRX -0.02%
FDMT -5.55%
FENC -2.52%
FGEN -9.83%
FHTX 8.21%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.57%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 1.27%
FULC 1.00%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -0.45%
GANX -3.08%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -2.88%
GHRS -3.72%
GLMD -4.09%
GLPG -1.71%
GLSI 5.01%
GLTO -3.31%
GLUE -3.69%
GLYC -12.49%
GMAB -0.50%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.35%
GNLX -4.65%
GNPX -3.43%
GNTA 3.94%
GOSS -9.55%
GOVX -1.36%
GOVXW 10.89%
GPCR -6.79%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.67%
GRTX -1.66%
GTHX 1.82%
GUTS 0.34%
GXGXW 41.67%
GYRE -4.97%
HALO -1.67%
HARP 0.09%
HCWB -6.13%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX -1.30%
HOOK 1.97%
HOTH -1.64%
HOWL 0.86%
HRMY 3.89%
HRTX 8.36%
HSTO 0.00%
HUMA 1.12%
HUMAW -6.26%
IBRX -6.46%
ICCC -3.10%
ICPT 0.21%
ICU 16.82%
ICUCW 9.30%
ICVX -0.91%
IDRA -23.04%
IDYA -3.21%
IFRX -2.78%
IGMS -1.46%
IKNA -1.18%
IKT -9.93%
IMAB 0.00%
IMCR -3.36%
IMGN 0.02%
IMGO 0.00%
IMMP 5.13%
IMMX -6.90%
IMNM 3.73%
IMNN 0.89%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.15%
IMTX -1.37%
IMTXW 6.00%
IMUX 2.30%
IMV 0.00%
IMVT -3.52%
INAB -0.72%
INBX -2.72%
INCY -2.25%
INDP 7.34%
INFI -52.38%
INKT 1.68%
INM 0.04%
INMB 3.91%
INO 2.86%
INSM -1.09%
INTS -1.96%
INVA 0.28%
INZY 1.83%
IOBT -10.24%
IONS 1.25%
IOVA -2.78%
IPA 3.00%
IPHA 5.18%
IPSC -2.73%
IRON -2.67%
ISEE 0.38%
ITOS 1.23%
ITRM 2.33%
IVA 6.96%
IVVD 0.00%
JAGX 1.54%
JANX -4.56%
JAZZ -1.01%
JNCE 0.00%
JSPR -2.25%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -2.45%
KALV -3.15%
KDNY 0.22%
KMPH -0.34%
KNSA -2.03%
KNTE -0.38%
KOD -7.71%
KPRX -4.08%
KPTI -8.57%
KRBP -10.00%
KRON 1.58%
KROS -0.53%
KRRO -2.17%
KRTX 0.03%
KRYS 0.11%
KTRA 13.94%
KTTA -0.65%
KTTAW 0.92%
KURA 0.63%
KYMR -3.37%
KYTX -4.13%
KZIA 0.35%
KZR -0.21%
LABP 0.57%
LBPH -0.32%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.78%
LENZ -2.78%
LEXX -1.54%
LEXXW -14.63%
LGND -1.18%
LGNDV 0.00%
LGVN -10.16%
LIAN -8.28%
LIFE 2.70%
LIPO -5.28%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -3.68%
LPTX -2.75%
LQDA 0.00%
LRMR 0.00%
LSTA -1.68%
LTRN 5.74%
LUMO 1.79%
LVTX -4.12%
LXEO -8.68%
LXRX -1.77%
LYEL -35.05%
LYRA 3.99%
MACK 0.10%
MBIO -11.34%
MBRX -1.43%
MCRB 2.94%
MDGL -2.24%
MDNA -13.16%
MDWD 3.56%
MDXG -2.28%
MEIP 0.00%
MESO -1.70%
MGNX -5.24%
MGTA -7.74%
MGTX -0.71%
MGX 2.14%
MIRM 0.45%
MIRO 0.59%
MIST 3.08%
MITO 0.00%
MLEC -5.95%
MLECW 2.31%
MLND -5.36%
MLTX -0.03%
MLYS -6.08%
MNKD -0.86%
MNMD 2.97%
MNOV -1.06%
MNPR -8.54%
MOLN 2.20%
MOR 0.42%
MORF -3.15%
MREO -1.00%
MRKR -0.43%
MRNA -9.21%
MRNS -5.51%
MRSN -2.62%
MRTX -0.17%
MRUS -0.36%
MRVI 0.07%
MTCR -1.29%
MTEM 6.93%
MTP -18.50%
MURA -4.02%
MYMD 1.08%
NAMS 0.00%
NAMSW -0.21%
NAUT 0.89%
NBRV 0.71%
NBSE -1.56%
NBTX 8.40%
NCNA 0.37%
NERV -1.58%
NEXI -0.74%
NGM -1.28%
NGNE 3.28%
NKGN 9.85%
NKGNW -18.03%
NKTR 3.27%
NKTX -3.26%
NLSP 3.53%
NLSPW 26.67%
NMRA -1.94%
NMTR -42.97%
NOVN -24.84%
NRBO 14.93%
NRIX -0.72%
NRSN -4.82%
NRSNW 0.00%
NRXP -7.46%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.62%
NTEC -12.45%
NTHI 0.00%
NTLA -5.46%
NTRBW -31.07%
NUVL -1.27%
NVAX -7.57%
NVCT -7.46%
NVIV -34.28%
NXTC -5.29%
NYMX -0.05%
OABI 2.77%
OABIW -10.06%
OBIO 1.90%
OBSV 0.00%
OCEA -2.82%
OCGN 8.02%
OCS -1.00%
OCUL 0.84%
OCUP 1.31%
ODT -4.27%
OKYO 1.72%
OLMA -5.12%
OMER -2.57%
OMGA -0.42%
ONCO 5.89%
ONCR -3.08%
ONCS 31.87%
ONCT -2.35%
ONCY 2.97%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT -4.00%
ORGS -0.69%
ORIC -3.56%
ORMP 18.04%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.25%
OVID 0.30%
OYST 0.00%
PALI -0.22%
PASG 0.00%
PBLA -7.50%
PBM -4.69%
PBYI 2.87%
PCSA -1.93%
PCVX -0.19%
PDSB -6.65%
PEPG 1.19%
PGEN -7.14%
PHAR 2.19%
PHAS 0.00%
PHAT -0.87%
PHIO -3.55%
PHIOW 36.47%
PHVS -5.83%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.47%
PLUR 7.39%
PMN -5.55%
PMVP -2.98%
PNT 0.16%
PPBT -6.87%
PRAX 7.28%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK -0.45%
PRQR 0.60%
PRTA -2.89%
PRTC 0.62%
PRTG 0.54%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.97%
PSTX -2.91%
PTCT -0.80%
PTE -0.82%
PTGX -1.26%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 3.75%
QLGN -2.78%
QNCX 5.70%
QNRX -0.08%
QSI -30.94%
QSIAW -3.13%
QTTB 1.83%
QURE -1.07%
RAIN -1.63%
RANI 4.81%
RAPT -1.95%
RARE 1.86%
RCKT -10.04%
REGN -0.36%
RENB -3.73%
REPL -2.21%
RETA 0.02%
REUN -0.89%
REVB -1.86%
REVBU 3.46%
REVBW 5.00%
RGLS -5.84%
RGNX -6.66%
RIGL -6.25%
RLAY -4.90%
RLMD 0.00%
RLYB -4.36%
RNA 1.75%
RNAC -4.53%
RNAZ -0.96%
RNXT 1.79%
ROIV -1.94%
ROIVW 4.56%
RPHM -1.55%
RPRX -0.63%
RPTX -0.59%
RUBY 2.70%
RVLP -32.05%
RVMD -0.93%
RVMDW -29.90%
RVNC -0.21%
RVPH -0.79%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.46%
RYTM -6.39%
RYZB 0.02%
RZLT 1.81%
SABS -1.37%
SABSW -11.81%
SAGE -0.05%
SANA -2.95%
SAVA -2.10%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 2.59%
SCPH 9.85%
SCPS 0.00%
SEEL -4.87%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.39%
SGMT -5.56%
SGTX -2.56%
SIOX 22.63%
SLDB -2.75%
SLGL 5.23%
SLN -7.25%
SLNO 0.74%
SLRX -0.81%
SLS -2.57%
SMMT -3.62%
SNDX 2.92%
SNGX 2.08%
SNPX 0.23%
SONN -2.15%
SPPI -0.49%
SPRB -1.36%
SPRC -4.25%
SPRO 0.75%
SRNE 0.00%
SRPT -1.28%
SRRA 0.00%
SRRK -1.73%
SRZN -2.45%
STAB 0.00%
STOK -7.21%
STRO -2.51%
STSA 0.00%
STTK 6.62%
SURF -0.93%
SVRA -2.24%
SWTX -0.49%
SYBX 1.29%
SYRS -2.24%
TALS -0.73%
TARA -7.38%
TARS -2.17%
TBPH 0.71%
TCBP 9.58%
TCDA 0.00%
TCON 0.00%
TCRR 0.00%
TCRT -1.75%
TCRX 4.52%
TECH -0.83%
TENX -0.32%
TERN -8.28%
TFFP -7.61%
TGTX -7.45%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -6.26%
TNGX -3.34%
TNXP -6.43%
TNYA -4.03%
TPST 5.37%
TRDA -4.81%
TRVI 2.68%
TRVN 0.67%
TSHA -18.86%
TSVT -4.26%
TTNP -6.05%
TVTX 3.08%
TYRA -6.83%
UBX -2.13%
UNCY -4.00%
URGN 2.49%
UTHR -0.19%
VACC 11.36%
VALN -6.70%
VAXX 106.25%
VBIV 0.91%
VBLT -8.77%
VCEL 0.98%
VCNX 8.60%
VCYT -1.01%
VERA -5.36%
VERU 3.02%
VERV -2.68%
VIGL -1.08%
VINC 2.93%
VIR -1.08%
VIRI -5.72%
VIRX 3.98%
VKTX -1.72%
VLON -13.04%
VNDA -3.99%
VOR -6.05%
VRCA 0.50%
VRDN -4.15%
VRNA -1.99%
VRPX 1.02%
VRTX 0.09%
VSTM 3.91%
VTGN -1.20%
VTVT 0.39%
VTYX -2.93%
VXRT -1.86%
VYGR -0.83%
VYNE -6.29%
VYNT 7.78%
WINT -2.72%
WVE -9.42%
XBIO 1.03%
XBIT 6.72%
XCUR 3.13%
XENE -1.76%
XERS 4.51%
XFOR 4.69%
XLO 4.42%
XLRN 0.00%
XNCR 0.26%
XOMA -8.79%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.55%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.72%
ZNTL -1.79%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2022-02-10 Aberman Zami Buy 80 616 Common Stock
2021-05-26 Clover Wolf Capital - Limited Partnership Sell 122 663 Common Stock
2021-05-26 Clover Wolf Capital - Limited Partnership Sell 22 015 Common Stock
2021-05-27 Clover Wolf Capital - Limited Partnership Sell 71 775 Common stock
2021-05-27 Clover Wolf Capital - Limited Partnership Sell 24 110 Common stock
INSIDER POWER
0.00
Last 98 transactions
Buy: 11 245 290 | Sell: 1 084 851

Volum Korrelasjon

Lang: 0.39 (neutral)
Kort: -0.82 (strong negative)
Signal:(32.85) Neutral

Pluristem Therapeutics Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pluristem Therapeutics Korrelasjon - Valuta/Råvare

The country flag -0.50
( neutral )
The country flag -0.12
( neutral )
The country flag 0.00
( neutral )
The country flag -0.36
( neutral )
The country flag 0.00
( neutral )
The country flag 0.85
( strong )

Pluristem Therapeutics Økonomi

Annual 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.770
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.770
FY 2020
Omsetning: $23 000.00
Bruttogevinst: $23 000.00 (100.00 %)
EPS: $-1.600
FY 2019
Omsetning: $54 000.00
Bruttogevinst: $52 000.00 (96.30 %)
EPS: $-2.90

Financial Reports:

No articles found.

Pluristem Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Pluristem Therapeutics

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA\'s Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 8.8645868301392 seconds
Number of API calls: 3
Number of DB calls: 9